News & CommentCancer Prevention

Tamoxifen's Trials and Tribulations

Science  10 Nov 1995:
Vol. 270, Issue 5238, pp. 910
DOI: 10.1126/science.270.5238.910

Summary

A controversial clinical trial to determine whether the drug tamoxifen can protect healthy women against breast cancer has run into a new obstacle. The National Heart, Lung, and Blood Institute, which was providing some funding, is reducing its commitment because it believes that the data will not shed light on tamoxifen's cardiovascular effects, as previously hoped.

Related Content